Literature DB >> 16162634

Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction.

T A M Kaandorp1, H J Lamb, E E van der Wall, A de Roos, J J Bax.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16162634      PMCID： PMC1769149          DOI： 10.1136/hrt.2003.025353

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  19 in total

1.  Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease.

Authors:  F M Baer; P Theissen; J Crnac; M Schmidt; H J Deutsch; U Sechtem; H Schicha; E Erdmann
Journal:  Eur Heart J       Date:  2000-06       Impact factor: 29.983

2.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 3.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

4.  F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.

Authors:  Matthias Schmidt; Eberhard Voth; Christian A Schneider; Peter Theissen; Rainer Wagner; Frank M Baer; Harald Schicha
Journal:  Magn Reson Imaging       Date:  2004-02       Impact factor: 2.546

5.  Accurate quantitation of regurgitant volume with MRI in patients selected for mitral valve repair.

Authors:  Jos J M Westenberg; Joost Doornbos; Michel I M Versteegh; Jeroen J Bax; Rob J van der Geest; Albert de Roos; Robert A E Dion; Johan H C Reiber
Journal:  Eur J Cardiothorac Surg       Date:  2004-12-19       Impact factor: 4.191

6.  Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation.

Authors:  R J Trent; G D Waiter; G S Hillis; F I McKiddie; T W Redpath; S Walton
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

7.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

8.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

9.  Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery.

Authors:  Ernst Wellnhofer; Adriana Olariu; Christoph Klein; Michael Gräfe; Andreas Wahl; Eckart Fleck; Eike Nagel
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

10.  Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy.

Authors:  Theodorus A M Kaandorp; Jeroen J Bax; Joanne D Schuijf; Eric P Viergever; Ernst E van Der Wall; Albert de Roos; Hildo J Lamb
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778
View more
  16 in total

Review 1.  Positron emission tomography and magnetic resonance imaging in heart failure.

Authors:  Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 2.  Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Authors:  D Le Guludec; R Lautamäki; J Knuuti; J J Bax; F M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-26       Impact factor: 9.236

3.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

4.  The role of cardiac magnetic resonance imaging following acute myocardial infarction.

Authors:  Dennis T L Wong; James D Richardson; Rishi Puri; Adam J Nelson; Angela G Bertaso; Karen S L Teo; Matthew I Worthley; Stephen G Worthley
Journal:  Eur Radiol       Date:  2012-03-25       Impact factor: 5.315

5.  Imaging: myocardial thinning is not always transmural scarring.

Authors:  Jeroen J Bax
Journal:  Nat Rev Cardiol       Date:  2013-05-07       Impact factor: 32.419

6.  Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes.

Authors:  Shaunagh McDermott; Ailbhe C O'Neill; Carole A Ridge; Jonathan D Dodd
Journal:  World J Cardiol       Date:  2012-04-26

Review 7.  Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches.

Authors:  Gaby Weissman; Federico M Asch
Journal:  J Cardiovasc Transl Res       Date:  2008-12-31       Impact factor: 4.132

Review 8.  Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI.

Authors:  Pier Giorgio Masci; Jan Bogaert
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

9.  Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.

Authors:  Stijntje D Roes; Theodorus A M Kaandorp; Nina Ajmone Marsan; Jos J M Westenberg; Petra Dibbets-Schneider; Marcel P Stokkel; Hildo J Lamb; Ernst E van der Wall; Albert de Roos; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

10.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.